title: Medullary carcinoma of the breast: a population-based perspective.
abstract: Prognostic factors specific to medullary carcinoma of the breast (MCB) are unknown. Our objective was to identify patient and tumor factors predictive of overall survival (OS) in a large cohort of MCB patients. The Surveillance, Epidemiology, and End Results database was used to identify patients with MCB diagnosed from 1988 to 2004. Patient, tumor, and treatment factors were compared by univariate analysis via the Kaplan–Meier method and survival differences detected using the log-rank test. A multivariate Cox proportional hazards model controlled for patient age, race, type of surgery, radiotherapy, tumor size, number of lymph node metastases (LNM), lymph node yield (LNY), estrogen receptor (ER) and progesterone receptor (PR) status, and extent of disease. On univariate analysis of 3,348 patients, factors influencing OS included age, race, tumor size, ER status, type of surgery, radiotherapy, LNM, LNY, and extent of disease (P<0.001). On multivariate analysis, advancing age (P<0.001), black race (P<0.001), regional metastases (P<0.001), distant metastases (P<0.001), increasing tumor size (P<0.001), ER positivity (P=0.003), and increasing LNM (P<0.001) were associated with decreased OS. An OS benefit was seen in PR-positive patients (P=0.002) and in those with increasing LNY (P<0.001). Even among node-negative patients, increasing LNY was associated with improved OS (P<0.001). Tumor size, LNM, regional and distant metastases, PR status, age, and race are important prognostic factors in MCB. ER positivity was associated with decreased OS, which may reflect inaccuracy in diagnosing MCB or a significant biologic variant. The improved OS seen with increasing LNY in node-negative patients suggests MCB may be currently understaged.
authors.affiliation: Department of Surgery, University of California Davis, Davis, CA, USA. steve.martinez@ucdmc.ucdavis.edu
authors.forename: Steve R
authors.initials: SR
authors.lastname: Martinez
authors.forename: Shannon H
authors.initials: SH
authors.lastname: Beal
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Canter
authors.forename: Steven L
authors.initials: SL
authors.lastname: Chen
authors.forename: Vijay P
authors.initials: VP
authors.lastname: Khatri
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Bold
mesh_terms: D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology; D018276:Carcinoma, Medullary / Q000401:mortality* / Q000473:pathology; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D018426:SEER Program
references.citation: Surg Gynecol Obstet. 1983 Dec;157(6):497-9
references.pmid: 6648768
references.citation: Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1040-7
references.pmid: 15990007
references.citation: Cancer Res. 2006 May 1;66(9):4636-44
references.pmid: 16651414
references.citation: Clin Cancer Res. 2008 Oct 15;14(20):6625-33
references.pmid: 18927304
references.citation: Cancer. 1988 Jun 15;61(12):2503-10
references.pmid: 2835145
references.citation: Breast Cancer Res Treat. 1990 Oct;16(3):215-29
references.pmid: 2085673
references.citation: Cancer. 2003 Sep 1;98(5):908-17
references.pmid: 12942556
references.citation: Br Med J. 1970 Jul 25;3(5716):181-8
references.pmid: 5448777
references.citation: J Clin Oncol. 2006 Apr 10;24(11):1656-64
references.pmid: 16505416
references.citation: J Surg Oncol. 1995 Oct;60(2):89-94
references.pmid: 7564387
references.citation: Breast Cancer Res Treat. 1989 Oct;14(1):91-9
references.pmid: 2605345
references.citation: Ann Oncol. 2001 Apr;12(4):525-33
references.pmid: 11398888
references.citation: Am J Surg. 2007 Oct;194(4):527-31
references.pmid: 17826073
references.citation: Mod Pathol. 1995 Jan;8(1):31-8
references.pmid: 7731939
references.citation: Cancer. 2002 Jun 1;94(11):2844-54
references.pmid: 12115371
references.citation: Med Oncol. 2010 Dec;27(4):1420-4
references.pmid: 20049562
references.citation: Cancer. 1980 Apr 15;45(8):2001-5
references.pmid: 6245787
references.citation: Am J Surg. 2008 Oct;196(4):495-9
references.pmid: 18809050
references.citation: J Surg Oncol. 1984 Feb;25(2):76-8
references.pmid: 6694404
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references.pmid: 11553815
references.citation: Cancer. 1977 Oct;40(4):1365-85
references.pmid: 907958
references.citation: J Natl Cancer Inst. 2005 Mar 16;97(6):439-48
references.pmid: 15770008